top of page
Search

Parkinson’s disease

  • Parkinson’s disease is a progressive neurodegenerative disorder affecting movement.

  • It is caused by the degeneration of dopamine-producing neurons in the substantia nigra, a part of the brain that controls movement.

Parkinson’s disease
Picture Representation of Parkinson’s disease

Causes

  • Genetic Factors: Mutations in specific genes (e.g., LRRK2, PARK2).

  • Environmental Factors: Exposure to toxins like pesticides and heavy metals.

  • Age: Incidence increases with age.

  • Gender: More common in men than in women.

Symptoms

1. Motor Symptoms:

  • Tremor: Shaking, often starting in one hand.

  • Bradykinesia: Slowness of movement.

  • Rigidity: Stiffness in limbs and trunk.

  • Postural Instability: Impaired balance and coordination.

2. Non-Motor Symptoms:

  • Cognitive impairment and dementia.

  • Mood disorders: Depression and anxiety.

  • Sleep disturbances: Insomnia, REM sleep behavior disorder.

  • Autonomic dysfunction: Constipation, orthostatic hypotension, and urinary problems.

Diagnosis

  1. Clinical Evaluation: Based on medical history and neurological examination.

  2. Imaging Tests: MRI or DaTscan (dopamine transporter scan) to support the diagnosis.

  3. Response to Medication: Improvement of symptoms with dopaminergic medications supports the diagnosis.

Pathophysiology of Parkinson’s Disease

Pathophysiology of Parkinson’s Disease
Pathophysiology of Parkinson’s Disease
  1. Dopamine Deficiency: Degeneration of dopaminergic neurons in the substantia nigra of the brain.

  2. Lewy Bodies: Abnormal aggregates of the protein alpha-synuclein inside neurons.

  3. Basal Ganglia Dysfunction: Impaired regulation of motor activity leading to symptoms like bradykinesia, tremors, and rigidity.

Treatment

1. Medications:

  • Levodopa: The most effective treatment, often combined with carbidopa.

  • Dopamine Agonists: Mimic dopamine effects (e.g., pramipexole, ropinirole).

  • MAO-B Inhibitors: Prevent breakdown of brain dopamine (e.g., selegiline, rasagiline).

  • COMT Inhibitors: Prolong the effect of levodopa (e.g., entacapone).

2. Surgical Treatment:

  • Deep brain stimulation (DBS) for patients with advanced symptoms not controlled by medication.

3. Physical Therapy:

  • To improve mobility, balance, and flexibility.

4. Occupational Therapy:

  • To assist with daily living activities.

5. Speech Therapy:

  • To address speech and swallowing difficulties.


bottom of page